USWM Enterprises LLC

On June 9, 2020, Supernus Pharmaceuticals acquired life science company US WorldMeds - CNS Portfolio from US WorldMeds Acquisition Highlights US WorldMeds LLC - CNS Portfolio (central nervous system) is involved in developing and commercializing products for the treatment of Parkinson’s disease. Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. Supernus Pharmaceuticals was founded in 2005 and is based in Rockville, Maryland. US WorldMeds is a Kentucky-based specialty pharmaceutical company that develops, licenses and commercializes unique medical therapies that address unmet patient needs. US WorldMeds’ products include novel treatments for malignant hyperthermia, cervical dystonia and symptoms of opiate withdrawal.